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ABSTRACT 
Prostacyclin (PGI2) induced a dose-dependent decrease in blood pres-
sure with slight increases in heart rate and body temperature, when ad-
ministered at the doses of 0.1-100 ~g into the lateral cerebral ven-
tricle (i.c.v.) of the urethane-anaesthetised rat. When the same doses 
were administered intravenously, both the blood pressure and heart rate 
decreased. Central pretreatment wib~ sodiurn meclofenamate (1 mg/rat 
i.c.v.) antagonised the central hypotensive effect of PGI 2 but i.c.v. 
pretreatrnent of the rats with indomethacin (1 mg/rat) failed to affect 
the PGI 2-induced hypotension. Central pretreatment with two histamine 
H2-receptor antagonists, cimetidine (500 ~g/rat i.c.v.) or metiamide (488 ~g/rat i.c.v.), antagonised the blood pressure lowering effect of 
0.1 ~g dose of PGI 2 but failed to affect the hypotension induced by 
higher PGI 2 doses. Therefore the main central hypotensive effect of PGI 2 
seems not to be associated with the stimulation of histamine H2 -recep-
tors in the brain. 
The hypotensive effect of i.c.v. administered PGI 2 appears to be due 
to an action upon the central nervous system rather than to a leakage 
into the peripheral circulation. This assurnption is supported by the 
fact that sodiurn meclofenamate i.c.v. antagonised the effect of PGI 2. 
In addition, the chronotropic response to i.c.v. PGI 2 was opposite to 
that induced by intravenous administration. The results also suggest 
that there may be differences in the mode of action between sodiurn 
meclofenamate and indomethacin. 
INTRODUCTION 
Prostacyclin (PGI 2) is formed from arachidonic acid in the rat brain (2). Intravenously (Lv.)administered PGI 2 causes a fall in blood pres-
sure and a slowing of the heart rate in the conscious rat (3). Recently 
it was reported that intracerebroventricular (i.c.v.) administration of 
PGI 2 induces a decrease in blood pressure of conscious rats (4). However, 
the possible concomitant effects of centrally administered PGI 2 on heart 
rate and body temperature have not been reported. 
In the present study increasing doses of PGI 2 were administered i.c.v. 
or i.v. to urethane-anaesthetised rats in order to obtain sirnultaneou9 
recordings of blood pressure, heart rate and body temperature. Since 
sodiurn meclofenamate interferes with the effects of exogenous prosta-
glandins bOtll in the peripheral tissues (5,6,7) and in the brain (8), 
it seemed worthwhile to examine the influence of this agent on the 
1 A preliminary report of this work has been presented at the Joint 
Meeting of the Gennan and Scandinavian Pharmacological Societies in 
TravemÜllde, FRG (1) 
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central effects of PGI 2 • For comparison, the effect of indomethacin, 
an equally effective inhibitor of prostaglandin biosynthesis as sodium 
meclofenamate (9), was studied. In our previous studies indomethacin 
and paracetamol antagonised the central hypotensive effect of clonidine 
(10). The hypotensive effect of clonidine can also be blocked by hista-
mine fh-receptor antagonists (11). Therefore the influence of cimetidine 
and metiamide, two histamine H2-receptor antagonists (11), on the cen-
tral PGI 2-induced hypotension was also studied. 
MATERIALS AND METHODS 
Male Wistar rats (260-360 g) were used. The rats were accommodated 
to standard ambient conditions for at least one week before the experi-
ments. The lights were on from 6 a.m. to 6 p.m. and the room was com-
pletely dark during the remaining 12 hours. The temperature was kept at 
22 oe and the relative humidity at 40%. The rats received standard rat 
pellets and tap water ad libitum. 
TIle rats were anaesthetised with urethane (1.5 g/kg i.p.). The tra-
chea was cannulated with a polyethylene tube and the rats were allowed 
to breathe spontaneously. The mean arterial blood pressure was measured 
from the left femoral artery by means of apressure transducer (Hewlett 
Packard 1280). The heart rate was calculated from the pulse waves by 
me ans of a rate computer (Hewlett Packard 88l2A). The left femoral vein 
was cannulated for intravenous injections. The rats were mounted in a 
stereotaxic instrument and tilted caudally so that the body formed an 
angle of 10 degrees wi th the horizontal plane. Intracerebroventricular 
injections were performed as described in detail by Paakkari (12). 
Briefly, an injection needle was introduced into the right lateral ven-
tricle of the brain. A polyethylene ca theter, fi11ed wi th the drug or 
control solution to be infused, was attached to the needle and the de-
sired amount of ~e solution was allowed to flow slowly by virtue of the 
hydrostatic pressure. The infusion was stopped by closing the upper end 
of the catheter. The proper position of the needle tip was ascertained 
at the end of each experiment by an injection of dye (Giemsa Solution, 
Merck) into the cerebral ventricle. The body temperature was measured 
rectally with a temperature recorder (ELLAB instruments, type TE 3, 
Copenhagen), a probe being introduced 5 cm into the rectum. A 60 W 
heating larnp was placed 20 cm above the rat. Experiments on control rats 
showed that this distance of the heating larnp was adequate to keep the 
body temperature at 37.l±0.4°C (mean±s.e.m.) in an ambient temperature 
of 22 oe. 
Administration of drugs 
Prostacyclin (PGI 2 ) sodium salt (kindly supplied by Dr. Pike, Upjohn 
Co.) was dissolved in 0.05% (w/v) NaOH, pH 12. The stock solution of 
PGI 2 , 10 mg/ml, was stored at O°C for 6 days maximally and further di-
luted immediately before each i.c.v. or i.v. injection. Trre dilutions 
were made in 0.9% (w/v) NaCl ( saline) for i.v. injections and for i.c.v. 
injections in a modified Krebs-Ringer bicarbonate buffer (NaCl 117 ruM, 
KCl 2.95 ruM, CaC1 2 1.44 mM, KH 2PO. 0.01 ruM, MgSO"x 7H2 0 1.12 mM and 
NaHC0 3 23.6 mM, pH 7.32) to simulate the concentrations found in the 
cerebrospinal fluid (13). The injection volume was 0.15 ml each for 
i.v. injections and 10 ~ each for i.c.v. injections. The control 
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animals received the same volume of the appropriate vehicle in each case 
(for the 100 ~g dose of PGl z the vehicle was 0.05% NaOH). Increasing 
doses of PGl z were injected i.c.v. at 45 rnin intervals in order to 
obtain time-response curves for various doses of PGl z. The i.v. inject-
ions were perforrned at 20 rnin intervals so that the effect of the pre-
ceding dose had cornpletely subsided. 
Indomethacin (Orion Pharrnaceutical Co., Helsinki) was dissolved in 
0.25 N NaOH and sodiurn meclofenarnate rnonohydrate (Parke, Davis & Co.) in 
saline. Cimetidine and metiamide (Srnith, Kline and French Laboratories 
Ltd.) were dissolved in 1 N HCl, pH adjusted to 6 with 0.1 N NaOH and 
then further diluted with saline. The influence of indomethacin, 
sodiurn meclofenamate, cimetidine and metiarnide on the central hypotensi-
ve effect of PGl z was studied after administration of these drugs i.c.v. 
10-20 rnin before the administration of the first dose of PGl z i.c.v. 
When increasing doses of PGl z were administered i.c.v. at 20 rnin inter-
vals, the hypotensive effect of the preceding dose had wholly subsided. 
The control animals received the same volume of the appropriate solvent 
in each case. 
The fall in blood pressure by hypotensive drugs is proportional to 
the blood pressure level before the administration of the drug (14). To 
rninirnize the influence on the resul ts of different blood pressure levels 
before the administration of the hypotensive agents, the hypotensive re-
sponses were calculated as percentages rather than absolute values. 
The Student's t-test was used to calculate the statistical signifi-
cance of the differences between the control and experimental groups. 
RESULTS 
I Effects of prostacyclin in non-pretreated rats 
E66eQ~ 06 PGI 2 o~ blood p~e6~~e (Fig. 1 and 2) 
Intracerebroventricular administration of PGl z at the doses of 0.1-
100 ~g/rat decreased the blood pressure in a dose-related manner. Intra-
venously, PGl z (0.001-100 ~g/rat) was even more potent as a hypotensive 
agent. The PGlz-induced hypotension was short-lasting both upon i.c.v. 
and i.v. administrations. The maximum effect was reached 1-2 rnin after 
each injection and the effect was cornpletely abolished in 10-20 rnin, 
with the exception of the largest i.v. dose which lowered blood pressure 
for 20-25 rnin. A slight hypertensive effect was observed after hypo-
tension at the PGl z doses of 1-100 ~g i.c.v. A negligible rise of blood 
pressure followed the hypotension also after administrations of 1-10 ~g 
doses of PGl z i.v. 
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Fig~e 1. Time-response effect of i.c.v. administered PGlz on b100d 
pressure in urethane-anaesthetised rats. Increasing doses of PGlz were 
administered i.c.v. at 45 min interva1s. The b100d pressure level 
(mean ± s.e.m.) before each i.c.v. injection was 118 ± 6 rum Hg in the 
contro1 graup (0-0), 108 ± 7 rum Hg in the 0.1 lJg of PGlz group (&--.) , 
112 ~ 9 rum Hg in the 1 lJg of PGl z group C.---.), 117 ~ 9 rum Hg in the 
10 lJg of PGl z group (.---.) and 120 ± 10 rum Hg in the 100 lJg of PGrz 
group (e---e). The differences between the base1ine levels of the groups 
are not statistica11y significant. Vertica1 bars indicate s.e.m. Con-
tra1 group comprised 10 rats, other groups 6 rats. *p<0.05, ** p<0.005 
and *** p<O.OOl v,o. contro1 group. 
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Fig~e 2. Dose-response effect of PGI 2 on blood pressure in urethane-
anaesthetised rats. Increasing doses of PGI 2 were administered i.c.v. 
Ce-e) or Lv. C .-.) at 20 min intervals . Open symbols are vehicle 
controls. The decreases in blood pressure represent the maximum effects 
1-2 min after each injection. The decreases in blood pressure induced by 
each PGI2 dose are significant at the p<O.OOl level as compared to the 
control values. The significance of the differences between the i.c.v. 
and Lv. groups are indicated by asterisks;**p<O.OOS and***p<O.OOl. 
Vertical bars indicate s.e.m. Each group comprised 6 rats. 
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E66eet 06 PGI z on he~t kate (Fig. 3) 
Intracerebroventricu1ar1y, PGI 2 at the doses of 0.1-100 ~g/rat in-
duced a neg1igib1e increase in heart rate. The maximum effect was reach-
ed 1-2 min after each injection and lasted 10-20 min with the exception 
of the 1argest dose which increased heart rate for 45 min. When 
administered intravenous1y, the same doses of PGI 2 had a slight brady-
cardic effect which was very short-1asting. The maximum decrease in 
heart rate was achieved 1-2 min after each injection and the effect was 
comp1ete1y abo1ished in 5 min • 
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Figune 3. Dose-response effect of PGI 2 on heart rate in urethane-
anaesthetised rats. Increasing doses of PGI 2 were administered i.c.v. 
Ce-e) or i.v. CA-A) at 20 min interva1s. The changes in heart rate 
represent the maximum effects 1-2 min after each injection. The differ-
ences in the changes of heart rate are not statistica11y significant. 
Vertica1 bars indicate s.e.m. Each group comprised 6 rats. 
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E66ect 06 PGI 2 on body temp~atune (Fig. 4) 
PGI z at the i.c.v. doses of 0.1-100 ~g/rat sli~lt1y increased the body 
ternperature. The maximum rise, about 0.5°C, was reached with the PGI z 
dose of 1 ~/rat. 1ntravenous1y, PGI z (0.001-100 ~g/rat) did not induce 
any significant changes in body ternperature (resu1ts not shown). 
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Figune 4. Time-response effect of i.c.v. administered PGI z on body 
ternperature in urethane-anaesti1etised rats. Increasing doses of PG1 z 
were administered i.c.v. at 45 min interva1s. The body ternperature level 
(mean ± s.e.m.) beiore each i.c.v. injection was 36.7 ± 0.4°C in the 
contro1 group (0-0), 36.0 ± 0.4°C in the 0.1 ~g of PGI z group (A-A) , 
36.5 ± 0.5°C in the 1 ~g of PGI z group (.-.), 37.1 ± 0.5°C in the 10 ~g 
of PGIz group (.-.) and 37.7 ± 0.5°C in the 100 ~g of PGI z group 
(e-e) . Vertica1 bars indicate s.e .m. Contro1 group cornprised 10 
rats, oti1er groups 6 rats. *p<0.05, **p<0.005 and ***p<O.OOl v-6. con-
tro1 group. 
11 Effects of sodium mec10fenamate and indomethacin 
Centrally adnünistered sodium mec10fenamate (1 mg/rat i.c.v.) induced 
a slight increase in heart rate but had no significant effects on the 
baseline va1ues for b100d pressure or body ternperature. I ndomethacin 
(1 mg/rat i.c.v.) did not affect b100d pressure, heart rate or body 
ternperature. 
111 Effect of prostacyc1in on b100d pressure in sodium 
mec10fenama te and indomethacin pretrea ted rats (Fig. 5) 
. Central pret:-eatment of the rats with sodium mec10fenamate (1 mg/rat 
~.~.v:) antagon~sed the hypotensive effect of i.c.v. administered PG1 z sh~ftlllg the d?se-:-esponse cl!rve for PGI z significantly to the right. 
Pretreatment w~th ~ndomethac~n (1 mg/rat i.c.v.) inhibited the hypotensive 
response to the 0.1 ~g dose of PGI z but fai1ed to antagonise the b100d 
pressure lowering effect of higher doses. 
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F~guhe 5. Effect of i.c.v. administered PGI 2 on blood pressure in 
sodium meclofenamate and indomethacin pretreated rats. Sodium meclo-
fenamate, 1 mg/rat C.-.), indomethacin, 1 mg/rat CA-A) or vehicle 
(0-0) was administered Lc.v. 20 min before connnencement of the ad-
ministration of PGI 2 • Increasing doses of PGI 2 were administered i.c.v. 
at 20 min intervals. The maximum changes in blood pressure at 1-2 min 
after each injection are shown. Vertical bars indicate s.e.m. Control 
group comprised 6 rats, sodium meclofenamate and indomethacin pretreated 
groups also 6 rats, except for the last dose (4 rats). *p<0.05 
**p<0.005 and ***~)<0.001 V<I. control group. 
IV Effects of cimetidine and metiamide 
Centrally administered cimetidine (500 ~g/rat i.c.v.) induced a signi-
ficant rise of blood pressure but had no effect on heart rate or body 
temperature. Metiamide (488 ~g/rat i.c.v.) induced short-lasting initial 
hypertensive and tachycardic effects. However, there was no significant 
difference between the baseline levels for blood pressure, heart rate or 
body temperature between metiamide and vehicle treated groups (see fig. 
6) . 
952 
V Effect of prostacyclin on blood pressure in cimetidine 
and metiamide pretrea ted rats (Fig. 6) 
Central pretreatment with cimetidine (500 ~g/rat i.c.v.) or metiamide 
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(488 ~/rat i.c.v.) antagonised the hypotensive effect of 0.1 wg of PGI 2 
i.c.v. but did not significant1y inf1uence the b100d pressure lowering 
effect of higher PGI 2 doses. 
10 
-~ 
~ 0 w 
a: 
-10 :::J 
lf) 
lf) 
W 
ce 
-20 a.. 
0 
0 
-30 <3 
CD 
z 
-40 
w 
~ 
z 
-50 
« 
I 1. 
u 
-60 
YI  
0 0.1 1.0 100 1000 
PG 12 (jJg/rat i.c.v.) 
Fig~e 6. Effect of i.c.v. administered PGI 2 on b100d pressure in 
cimetidine and metiamide pretreated rats. Cimetidine, 500 ].Jg/rat (.-.) , 
me ti amide , 488 Jlg/rat (e-e), or vehic1e (0-0) was administered i.c.v. 
10 or 15 min be fore commencement of the administration of PGI 2. Increas-
ing doses of PGI 2 were administered i.c.v. at 20 min interva1s. The 
maximum changes in b100d pressure at 1-2 min after each injection are 
shown. Vertica1 bars indicate s.e .m. Each group comprised 6 rats. 
*p<0.05 and **p<0.005 V.6. contro1 group. 
DISCUSSION 
PGI2 i.c.v. decreased the b100d pressure of urethane-anaesthetised 
rats in a dose-re1ated manner and slightly increased the heart rate and 
body ten~erature. PGI2 lowered the b100d pressure also after intravenous 
administration. Since prostaglandins are known to cross the b1ood-brain 
barrier (15), the possibi1ity cannot be exc1uded that the resu1ts obtain-
ed are due to a 1eakage of PGI 2 into the peripheral circu1ation. How-
ever, the rapid onset of the hypotensive response after i.c.v. adminis-
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trations suggests that this effect may have been due to an influence of 
PGI 2 on the blood pressure regulating centres of the brain. In addition, 
PGI 2 slightly decreased the heart rate upon intravenous administration. 
Moreover, PGI 2 elevated the body temperature upon i.c.v. but not upon 
i.v. administrations. This finding further suggests that the effects of 
centrally administered PGI 2 are due to an action on the structures of 
the brain. The antagonism of the hypotensive effect of PGI 2 by central 
pretreatment with sodium meclofenamate also lends support to the as-
sumption of a central site of action for PGI 2• In agreement with the 
present results i.c.v. applied PGI 2 at the doses of 1.25-10 llg/kg dose-
dependently decreased the blood pressure of conscious rats (4). Since 
PGI2 is abundantly present in the brain (2, 16, 17, 18) and excerts a 
strong dose-related hypotensive effect also after central administration, 
this agent might be associated with the central control of blood pressure. 
Centrally adnrinistered arachidonic acid and several of its metabolites, 
including PGE2 and PGF 2a, induce hypertilermia both in urethane-anaesthe-
tised (8,19,20,21) and conscious rats (22). In fact, in our previous 
study with urethane-anaesthetised rats (8) PGF2a Lc.v. had a strong 
dose-dependent hyperthermie effect wi th a maximum about +2.6 oe. Hyper-
thermia following i.c.v. administration of PGI 2 has been reported in 
conscious cats and rabbits but the doses of PGI 2 sufficient to induce 
temperature rises were over 10 times higher than those of PGE2 (23). 
Furthermore, i.c.v. administration of PGI 2 at the doses of 50-500 llg/kg 
caused dose-dependent hypotilermic response in conscious guinea-pigs 
whereas smaller doses (3-30 llg/kg) had no consistent effect on body 
temperature (24). In the present study PGI 2 i.c.v. had only weak effect 
on body temperature of uretilane-anaestiletised rats. The failure of PGI 2 
to induce any considerable temperature change could hardly be due to 
the use of alkaline solvent, since NaOH at even more alkaline concentrat-
ions than used here had no effect on the hyperthermie responses to 
PGF2a or PGE2 in rats (own unpublished findings). Thus PGI2, unlike the 
other prostaglandins, seems to interfere preferentially with the central 
blood pressure regulation but not or only minimally with the central 
thermo regulation of the rat. 
Central pretreatment with sodium meclofenamate antagonised the central 
hypotensive effect of PGI2, while indomethacin did not share this effect. 
This finding lends further support to our previous suggestion that there 
may be differences in the mode and/or site of action between sodium meclo-
fenamate and indomethacin. Since indomethacin is a highly lipid-soluble, 
agent (25), the possibility cannot be excluded that the lack of effect of 
indomethacin is due to its leakage into the periphery. Previous studies 
have shown that, in addition to the potent inhibition of prostaglandin 
biosynthesis (9), sodium meclofenamate and the other fenamates also antag-
onise the effects of exogenous prostaglandins in many peripheral tissues 
(5,6,7). However, the central cardiovascular and thermal effects of PGF2a 
were not influenced by central pretreatment with sodium meclofenamate but, 
paradoxically, were enhanced by subcutaneous pretreatment with this agent 
(8) • 
TIle antihypertensive agent clonidine is known to stimulate the synthe-
sis of prostaglandins in the rat brain (26). Indomethacin and paracetamol 
whidl both effectively inhibit the brain prostaglandin synthesis (27) 
antagonised the central hypotensive effect of clonidine in rats (10). 
It has been therefore suggested that PGI2 or some other hypotensive meta-
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bo1ite of arachidonic acid in tile rat brain might be associated with the 
centra1 hypotensive effect of c10nidine (10). C10nidine stimulates also 
histamine H2-receptors in the brain (11). Centra1 pretreatment with the 
histamine H2 -receptor antagonists blocks the hypotensive effect of 
c10nidine (11). Thus the stimulation of the histamine H2 -receptors has 
been imp1icated in the centra1 hypotensive effect of c10nidine (11). In 
the present study centra1 pretreatment with cimetidine or metiamide, two 
antagonists of the histamine H2 -receptors (11), abolished the slight 
hypotensive response to 0.1 ~g of PGI 2 but did not affect the b100d pres-
sure lowering effect of higher doses. The lack of antagonism at the 
]1igher doses of PGI 2 might indicate that the dose of cimetidine and 
metiamide was just not adequate to provide receptor blockade in the 
appropriate part of the brain. However, bOtil cimetidine and metiamide 
blocked effective1y the histamine H2 -receptors even at lower doses than 
those used in the present experiments (28). Furthermore, the centra1 
hypothermie effect of PGI 2 in guinea-pigs was attenuated by considerab1e 
smaller doses of metiamide than that used in this study (24). The hypo-
tensive effect of PGI 2 i.c.v. seems therefore not to invo1ve a stimulat-
ion of cerebra1 histamine H2-receptors. 
Since PGI 2 is present in the brain (2,6,17,18) and exerts strong dose-
re1ated hypotensive effect upon centra1 administration, this agent might 
participate in the centra1 regulation of b100d pressure. 
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